Oxford Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Oxford Asset Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,940	Closed	-$80K	–	1412
2019 Q4	$80K	Buy	+1,940	New	+$42.5K	﹤0.01%	1637
2019 Q3	–	Sell	-799	Closed	-$28K	–	1992
2019 Q2	$28K	Buy	+799	New	+$43.3K	﹤0.01%	1650
2019 Q1	–	Sell	-3,042	Closed	-$146K	–	2062
2018 Q4	$146K	Buy	+3,042	New	+$167K	﹤0.01%	1599

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Oxford Asset Management's VBIV Position: Q1 2020 in Review

Oxford Asset Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2020, closing a stake of 1,940 shares — an estimated $80K sold.

Oxford Asset Management first reported a position in VBIV in Q4 2018 and held it in 3 quarters. The position peaked at $146K in Q4 2018. 71 funds tracked by Wall St. Rank hold VBIV as of Q1 2020.

Oxford Asset Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 1,940 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2020, an estimated $80K.
Oxford Asset Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2018 and held it in 3 quarters.
Oxford Asset Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $146K in Q4 2018.
71 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.